Cargando…

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma

Detalles Bibliográficos
Autores principales: Linton, Kim, Dreyling, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437561/
https://www.ncbi.nlm.nih.gov/pubmed/32885149
http://dx.doi.org/10.1097/HS9.0000000000000464
_version_ 1783572646320930816
author Linton, Kim
Dreyling, Martin
author_facet Linton, Kim
Dreyling, Martin
author_sort Linton, Kim
collection PubMed
description
format Online
Article
Text
id pubmed-7437561
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-74375612020-09-02 EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma Linton, Kim Dreyling, Martin Hemasphere Editorial Wolters Kluwer Health 2020-08-17 /pmc/articles/PMC7437561/ /pubmed/32885149 http://dx.doi.org/10.1097/HS9.0000000000000464 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Editorial
Linton, Kim
Dreyling, Martin
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
title EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
title_full EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
title_fullStr EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
title_full_unstemmed EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
title_short EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma
title_sort eha endorsement of esmo clinical practice guidelines for newly diagnosed and relapsed mantle cell lymphoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437561/
https://www.ncbi.nlm.nih.gov/pubmed/32885149
http://dx.doi.org/10.1097/HS9.0000000000000464
work_keys_str_mv AT lintonkim ehaendorsementofesmoclinicalpracticeguidelinesfornewlydiagnosedandrelapsedmantlecelllymphoma
AT dreylingmartin ehaendorsementofesmoclinicalpracticeguidelinesfornewlydiagnosedandrelapsedmantlecelllymphoma